Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

30 May 2019 07:00

RNS Number : 5394A
Plutus PowerGen PLC
30 May 2019
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Plutus PowerGen Plc / Ticker: PPG / Index: AIM

30 May 2019

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

 

Trading Update

 

Plutus PowerGen (AIM: PPG), the AIM listed power company focused on the development and operation of flexible energy generation ("FlexGen") projects in the UK, is pleased to provide an update on corporate and operational activities across its portfolio.

 

Highlights and trading update

 

· Six 20MW Rockpool funded sites, in which Plutus has a 44.5% carried interest, generated approximately £1.9m EBITDA (unaudited) for the 11 months ended 31 March 2019. This is before Capacity Mechanism ("CM") receipts which are expected to average circa £3m per annum from 2020 onwards, index linked, for the six operating companies when received (further details provided below)

· Gas site being developed with Rockpool proceeding

· Assembling gas site portfolio - two 20MW sites in planning with additional sites in the pipeline

· Appointed DWPF Ltd ("DWPF") as formal intermediary to assist in securing the equity portion within Special Project Vehicles ("SPVs") for the contemplated gas site portfolio

· Plutus trading in line with management expectations with small operating loss anticipated for the year ended 30 April 2019 and break even in the year ending 30 April 2020 before financing costs for the new gas sites

· Cash at 30 April 2019 was £64,105 (31 October 2018: £63,000) principally due to the £500,000 gross raised in mid-November much of which has been disbursed on site development. Certain management fees are being accrued due to the delay in CM payments and the temporary suspension of the CM market pending resolution of certain reviews, although auctions are still taking place. The government continues to support the CM. Accordingly, the directors are matching these accruals with regard to their directors' fees to maintain a cash flow equilibrium and therefore the directors are confident that they have sufficient resources under the current cash burn to implement their current plans.

 

The appointment of DWPF, as its formal intermediary to assist it in securing the equity portion within SPVs for the contemplated gas site portfolio, is a positive move for Plutus. DWPF are specialists in structuring and arranging projects as well as securing infrastructure finance for substantial civil/energy/infrastructure projects across the UK, DWPF have previously raised over £6 billion of funding in over 130 completed transactions. DWPF has already received interest in the approximate 70% of complementary asset financing required and is in positive discussions with several parties regarding the more challenging equity portion. Whilst there can be no guarantee that either or both of the required equity and asset financing can be obtained at a commercially acceptable rate, the Board are pleased with the non-binding indications of interest received to date.

 

Plutus' acting CEO James Longley said, "I am very pleased with recent developments as we focus on creating a portfolio of profitable operations within the robust flexible energy sector. Most notably, the agreement with DWPF to secure the equity portion for our planned gas site portfolio will enable us to implement our strategy in a timely manner and achieve Group break even in the year to 30 April 2020. The CM reviews are frustrating but are largely out of our hands and we look forward to their reinstatement. I look forward to providing our shareholders with further updates in due course."

 

**ENDS**

 

For further information, please visit www.plutuspowergen.com, or contact:

 

James Longley

Plutus PowerGen Plc

Tel: +44 (0) 20 8720 6562

David Foreman

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

Richard Salmond

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

Andy Thacker

Turner Pope

Tel: +44 (0) 20 3621 4120

Isabel de Salis

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFIFEAIAFIA
Date   Source Headline
5th Aug 20107:00 amRNSNotice of General Meeting
30th Jul 20107:00 amRNSPreliminary Results 2010
27th Jul 20103:15 pmRNSIssue of Equity
12th Jul 20107:00 amRNSChange of Adviser
25th Jun 20107:00 amRNSTHERAKIND SALE OF INTEREST IN PRODUCT
22nd Jun 20107:00 amRNSIPSO SIGNS COLLABORATION AGREEMENT WITH B1 MEDICAL
12th May 20107:00 amRNSMedermica Files Second Technology Patent
30th Apr 20107:00 amRNSTotal Voting Rights
1st Apr 20109:28 amRNSIssue of New Shares
9th Mar 20107:00 amRNSAXILICA WINS SUBSTANTIAL GRANT
15th Feb 20107:00 amRNSPolyfect enters due diligence agreement
29th Jan 20107:00 amRNSInterim Management Report 2009
14th Jan 20107:00 amRNSIPSol Energy first customer revenues
30th Nov 20097:00 amRNSTotal Voting Rights
6th Nov 200912:19 pmRNSIssue of Shares
6th Nov 200911:39 amRNSDirector's Interest in Shares and Share Options
5th Nov 200910:02 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSIpso Creates Photovoltaic Testing Business
19th Oct 20097:00 amRNSpH Technology - Development Agreement Signed
15th Oct 20097:00 amRNSTherakind Product Update
11th Sep 20098:42 amRNSResult of AGM
24th Jul 20097:00 amRNSPreliminary Results 2009
8th May 20097:00 amRNSMedermica Files Technology Patent
3rd Apr 20097:00 amRNSSuccessful Fundraising for Therakind
27th Feb 20092:54 pmRNSDirector/PDMR Shareholding
19th Jan 20097:00 amRNSInterim Results
17th Dec 20087:00 amRNSChange of Registered Office
18th Nov 20081:16 pmRNSIssue of New Shares
17th Nov 20084:00 pmRNSAppointment of Joint Broker
4th Nov 20087:00 amRNSAcquisition of Cambridge Meditech
30th Sep 20087:00 amRNSAxilica Limited Update
25th Jul 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSInvestment in Polyfect Soluti
10th Jan 20087:01 amRNSInterim Results
24th Oct 20072:23 pmRNSAnnual Report and Accounts
25th Sep 20077:00 amRNSInvestment in Axilica
10th Sep 20074:10 pmRNSAdditional Listing
20th Aug 20077:02 amRNSRe: AIM Rule 26
25th Jul 20077:00 amRNSFinal Results
17th Jul 200711:47 amRNSDirector/PDMR Shareholding
5th Jul 20077:01 amRNSFurther investment in IWC
15th Jun 20077:00 amRNSTherakind Investment Update
1st Jun 20077:01 amRNSTotal Voting Rights
23rd May 20072:00 pmRNSIssue of Equity
30th Mar 20075:04 pmRNSTotal Voting Rights
21st Mar 200710:45 amRNSHolding(s) in Company
8th Mar 200711:52 amRNSIssue of Equity
7th Mar 20078:05 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.